serpin family D member 1 ; Homo sapiens






182 Article(s)
Download
PMID
Title
Journal
Pub. Date
#Total Relationship(s)
1 1333106 The inhibition of thrombin and chymotrypsin by heparin-cofactor II. Thromb Res 1992 Oct 1 6
2 1381849 Heparin cofactor II deficiency in the elderly: comparison with antithrombin III. Thromb Res 1992 Jun 1 1
3 1381850 Modulation of heparin cofactor II activity by glycosaminoglycans and adhesive glycoproteins. Thromb Res 1992 Jun 1 12
4 1442260 The interaction of glycosaminoglycans with heparin cofactor II: structure and activity of a high-affinity dermatan sulfate hexasaccharide. Adv Exp Med Biol 1992 11
5 1521342 An enzyme-linked immunosorbent assay for heparin cofactor II (HCII). Application to the measurement of HCII in clinical materials. Clin Chim Acta 1992 Jan 31 4
6 1554154 Interaction between histidine-rich glycoprotein and platelet factor 4 with dermatan sulfate and low-molecular-weight dermatan sulfate. Angiology 1992 Jan 1
7 1579900 Use of purified dermatan sulfate for heparin cofactor II (HC II) assay. Thromb Res 1992 Jan 15 2
8 1646210 Immobilization of dermatan sulphate on a silica matrix and its possible use as an affinity chromatography support for heparin cofactor II purification. J Chromatogr 1991 Feb 22 11
9 1671335 Complete nucleotide sequence of the gene for human heparin cofactor II and mapping to chromosomal band 22q11. Biochemistry 1991 Feb 5 4
10 1718466 Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis. Blood Coagul Fibrinolysis 1991 Jun 1
11 1831893 [Recurrent venous thromboembolism caused by heparin cofactor II deficiency. A case]. Presse Med 1991 Jul 6-13 1
12 1939083 The N-terminal acidic domain of heparin cofactor II mediates the inhibition of alpha-thrombin in the presence of glycosaminoglycans. J Biol Chem 1991 Oct 25 4
13 1962908 Effect of low molecular weight heparin preparations on the inhibition of thrombin by heparin cofactor II. Semin Thromb Hemost 1990 Oct 4
14 1962909 Comparative studies of heparin cofactor activity toward antithrombin III and heparin cofactor II, and antithrombin III affinity between low molecular weight heparin and unfractionated heparin. Semin Thromb Hemost 1990 Oct 3
15 1994003 Pharmacological characteristics of high-affinity serotonin uptake systems established through gene transfer. J Pharmacol Exp Ther 1991 Feb 2
16 2028443 Heparin cofactor II: experimental approach to a new assay and clinical results. Thromb Res 1991 Feb 1 1
17 2045458 Purification of heparin cofactor II from human plasma. J Chromatogr 1991 Feb 22 5
18 2068567 Molecular profile and mapping of dermatan sulfates from different origins. Semin Thromb Hemost 1991 2
19 2096488 Increased heparin cofactor II levels in women taking oral contraceptives. Thromb Haemost 1990 Nov 30 2
20 2099324 Evidence for a reduced heparin cofactor II biological activity in diabetes. Haemostasis 1990 1
21 2122537 Heparin cofactor II inhibits thrombin-stimulated release of tissue plasminogen activator from cultured human endothelial cells in the presence of dermatan sulfate. Thromb Res 1990 Jul 15 3
22 2196322 Characteristics of the chemotactic activity of heparin cofactor II proteolysis products. J Leukoc Biol 1990 Aug 2
23 2211700 Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity. J Biol Chem 1990 Oct 25 13
24 2266131 Glycosaminoglycan-mediated leuserpin-2/thrombin interaction. Structure-function relationships. J Biol Chem 1990 Dec 25 3
25 2318889 On the activation of human leuserpin-2, a thrombin inhibitor, by glycosaminoglycans. J Biol Chem 1990 Mar 25 6
26 2432917 Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides. Br J Haematol 1986 Dec 4
27 2436330 Effect of pentosan polysulphate administration in man on the formation of covalent complexes between heparin cofactor II and thrombin generated in plasma by contact activation. Thromb Haemost 1986 Dec 15 2
28 2436331 Comparative turn-over of heparin cofactor II and antithrombin III in baboons. Influence of heparin and pentosan polysulfate administration. Thromb Haemost 1986 Dec 15 3
29 2512688 Interaction of thrombin with heparin cofactor II and antithrombin III on prostacyclin production by cultured endothelial cells. Thromb Res 1989 Oct 1 7
30 2713501 Heparin cofactor II-proteinase reaction products exhibit neutrophil chemoattractant activity. Blood 1989 May 1 3
31 2760054 Antithrombin activity of a peptide corresponding to residues 54-75 of heparin cofactor II. J Biol Chem 1989 Aug 25 3
32 2894851 Heparin cofactor II: cDNA sequence, chromosome localization, restriction fragment length polymorphism, and expression in Escherichia coli. Biochemistry 1988 Jan 26 6
33 2922702 Structural features of heparin and their effect on heparin cofactor II mediated inhibition of thrombin. Thromb Res 1989 Jan 1 5
34 2998359 Biosynthesis of functionally active heparin cofactor II by a human hepatoma-derived cell line. Biochem Biophys Res Commun 1985 Oct 15 3
35 3003690 A new member of the plasma protease inhibitor gene family. Nucleic Acids Res 1986 Jan 24 2
36 3169238 Antithrombin action of phosvitin and other phosphate-containing polyanions is mediated by heparin cofactor II. FEBS Lett 1988 Sep 12 8
37 3178923 Azathioprine lymphocytotoxicity. Potentially lethal damage by its imidazole derivatives. Arzneimittelforschung 1988 Jun 2
38 3183355 Plasma heparin cofactor II in alcoholic liver disease. J Hepatol 1988 Aug 1
39 3217919 A simple method to measure dermatan sulfate at sub-microgram concentrations in plasma. Thromb Haemost 1988 Oct 31 4
40 3301469 The role of heparin cofactor II in the modulation of hemostasis. Dev Biol Stand 1987 2
41 3348170 Heparin cofactor II assay. Elimination of heparin and antithrombin-III effects. Am J Clin Pathol 1988 Mar 4
42 3401503 Studies on the structural requirements of heparin for the catalysis of thrombin inhibition by heparin cofactor II. Biochim Biophys Acta 1988 Aug 11 4
43 3426230 Structure-function relationships in heparin cofactor II: spectral analysis of aromatic residues and absence of a role for sulfhydryl groups in thrombin inhibition. Arch Biochem Biophys 1987 Dec 14
44 3518132 Heparin cofactor II: purification and antibody production. Thromb Haemost 1986 Feb 28 9
45 3603428 Consumption of heparin cofactor II (dermatan sulfate cofactor) and antithrombin during coagulation. Thromb Res 1987 Apr 15 1
46 3619144 [The second cofactor of heparin]. Ann Biol Clin (Paris) 1987 3
47 3660328 Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis. Thromb Haemost 1987 Jun 3 4
48 3675584 Carboxylate polyanions accelerate inhibition of thrombin by heparin cofactor II. Biochem Biophys Res Commun 1987 Oct 14 6
49 3691797 Binding of heparin or dermatan sulfate to thrombin is essential for the sulfated polysaccharide-accelerated inhibition of thrombin by heparin cofactor II. FEBS Lett 1987 Dec 10 16
50 3755134 Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II. J Biol Chem 1986 Jul 5 17